The precision diagnosis of diabetes is an increasingly important part of understanding the full spectrum of disease heterogeneity, and several groups have recently outlined current and future roles for precision medicine approaches in diabetes (1–4). Patients with monogenic or syndromic diabetes are often misdiagnosed as having type 1 or type 2 diabetes (5,6), so it remains a pressing question how patients with atypical presentations of diabetes should be evaluated and what role precision medicine should have in their care. This exact question is raised in the thought-provoking case report presented by Spira et al. (7) in this issue of Diabetes Care, who describe a patient found to have a previously unidentified variant in the WRN gene, which is associated with Werner syndrome (WS) as well as diabetes, insulin resistance, and hirsutism.
http://dlvr.it/T5lrY8
ليست هناك تعليقات:
إرسال تعليق
ملحوظة: يمكن لأعضاء المدونة فقط إرسال تعليق.